Novo Nordisk (NVO.US) sees weight-loss drug sales surge 40% in April after price cuts in India

老虎证券2026/05/08 11:56

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

According to market research firm Pharmarack, sales of Wegovy, Ozempic, and their partner brand versions reached 32,000 units in April, marking the first full month of data since generic semaglutide was launched in India. Starting from April 1, Novo Nordisk lowered the starting dose prices of both drugs by 36% and 48% respectively, bringing the price down to 5,660 rupees (approximately 60 US dollars).

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Kevin Hassett, Director of the White House National Economic Council, stated that the recent substantial decline in technology stocks does not indicate a comprehensive sell-off risk for the AI industry. He acknowledged that some enterprises are indeed burdened with significant debt, which warrants attention. However, he also pointed out that there are many financially strong companies within the industry that hold both equity and debt in related firms; these companies may be poised to acquire or provide funding support when opportunities arise.

华尔街见闻•2026/11/02 20:01